CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, is pleased to announce the appointment of Dr. Till Puschmann as Vice President of R&D and Business Development and member of the management team.

Till joined CellGenix in 2018 as Business Development & Senior Project Manager. As Vice President R&D and Business Development, Till will now be responsible for the development of CellGenix’ product portfolio and broadening of the pipeline. He also still acts as Senior Project Manager steering and supporting interdepartmental projects.

Read full press release